SLC6A3 and Alzheimer disease: Dopamine transporter (DaT) imaging24 and [123I] MIBG cardiac sympathetic nerve scintigraphy25 are authentic in clinically discriminating DLB from AD, and the DLB guidelines treat DaT imaging and [123I] MIBG scintigraphy as indicative biomarkers26.